2020
DOI: 10.1016/j.jconrel.2020.01.052
|View full text |Cite
|
Sign up to set email alerts
|

The clearance and biodistribution of magnetic composite nanoparticles in healthy and osteoarthritic rat knees

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
14
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 24 publications
(16 citation statements)
references
References 53 publications
2
14
0
Order By: Relevance
“…In a rat OA model, increased particle retention (in 14 days) has been found in 15-month rat knees, compared to 5-and 10-month rat knees (Fig. 3c) [33]. Although no animal study precisely recapitulates how the pathophysiology of OA affects the clearance of nanoparticles from lymphatic pathway, we can speculate that the initial 'expansion' phase of lymphatic vessels during moderate experimental arthritis may facilitate efficient lymphatic clearance; in contrast, the collapsed phase of lymphatic vessel characterized by lymphatic vessel structural damage and loss of contraction may reduce lymphatic clearance of nanoparticle or their encapsulated drugs [17].…”
Section: Pharmacokinetics and Biodistribution Of Nanoparticlesmentioning
confidence: 79%
See 1 more Smart Citation
“…In a rat OA model, increased particle retention (in 14 days) has been found in 15-month rat knees, compared to 5-and 10-month rat knees (Fig. 3c) [33]. Although no animal study precisely recapitulates how the pathophysiology of OA affects the clearance of nanoparticles from lymphatic pathway, we can speculate that the initial 'expansion' phase of lymphatic vessels during moderate experimental arthritis may facilitate efficient lymphatic clearance; in contrast, the collapsed phase of lymphatic vessel characterized by lymphatic vessel structural damage and loss of contraction may reduce lymphatic clearance of nanoparticle or their encapsulated drugs [17].…”
Section: Pharmacokinetics and Biodistribution Of Nanoparticlesmentioning
confidence: 79%
“…Synovial fluid and serum tend to equilibrate through synovium intercellular gaps in a normal status; in OA, synovial inflammation-associated increased capillary permeability facilitates the elimination of nanoparticles from joint [31]. However, the clearance of nanoparticles in OA joint is impaired compared with the healthy joint, which may be associated with synovial thickening [33,34]. Ageing associated metabolic changes, including less range of joint motion and decreased lubricating fluid, may also impede the clearance of nanoparticles.…”
Section: Pharmacokinetics and Biodistribution Of Nanoparticlesmentioning
confidence: 99%
“…The number of rats in each group was chosen based on the calculation formula reported by Charan and Kantharia 20 . After a 1-week acclimation period, 24 rats underwent surgery for the radial transection of the medial meniscus to generate an OA model 21 , while the remaining 12 rats received a sham operation. Then, the rats were randomly grouped into either the 4 or 8 weeks of the sham, OA, or OA with CPS treatment (OA + CPS) groups ( n = 6, each group).…”
Section: Methodsmentioning
confidence: 99%
“…These vehicles have been shown to be susceptible to microvascular and synovial macrophage‐mediated drainage and can be retained in the joint space only for few weeks, depending on their size, charge and composition 9,64,76,77 . In fact, Partain et al determined that particles of around 190 nm in diameter, composed of poly(ethylene glycol)‐ploy(lactic acid) copolymer containing magnetic nanoparticles, can be retained for around 2 weeks after IA injection in a rat model of knee OA 78 . The use of larger particles that could better avoid lymphatic drainage and cell‐mediated particles elimination (Figure 1) is a potential strategy to achieve IA drug sustained release over longer periods of time.…”
Section: Intra‐articular Drug Delivery Strategies In Oamentioning
confidence: 99%